Skip to main content
v2026.11,610 entries · CC-BY 4.0

Service Level Agreements (SLAs) in Medical Supply Vendor Contracts

What actually belongs in an SLA with a medical-supply vendor — on-time delivery percentage, order-accuracy rate, tiered response-time commitments — and the remedy structures (service credits, corrective action plans, termination rights) that make those commitments enforceable.

Ask about Service Level Agreements (SLAs) in Medical Supply Vendor Contracts

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Written and maintained by CASRAI Editorial Board

Last updated

What “the SLA” Actually Means in a Medical Supply Contract

In a medical supply distributor or vendor contract, the phrase “SLA” gets used loosely — sometimes for a full service-level exhibit with numeric targets, sometimes just for a vague sentence promising “reliable service.” Only the first one is worth anything when a delivery is late or an order arrives wrong. This page covers what actually belongs in that exhibit: the specific commitments to negotiate, how to phrase them so they’re enforceable, and what a real remedy structure looks like when a target is missed — as distinct from a scorecard that measures performance against those targets after the fact (see vendor scorecard metrics for the measurement side).

An SLA is a contract exhibit, not a marketing claim. A distributor’s sales material saying “99% on-time delivery” means nothing contractually unless that number, its measurement method, and a consequence for missing it are written into the agreement itself — typically as a schedule or exhibit attached to the master service agreement that governs the overall relationship.

The Core Commitments Worth Negotiating

A medical-supply SLA doesn’t need to cover everything a vendor could theoretically be measured on. It needs a small number of commitments that are (a) measurable from records either party actually keeps, and (b) tied to something that matters operationally — a stockout, a patient-facing delay, a billing error. Four show up in nearly every workable medical-supply SLA:

On-Time Delivery Percentage

The single most common SLA metric, and the one most often written ambiguously. The contract language needs to answer three questions the way most template language doesn’t:

  • On time against which date? The date requested on the purchase order, or a date the vendor confirmed after the fact? Measuring against a vendor-revised confirmation date lets a distributor push a promised date back and then hit their own moved target — technically “on time,” operationally still late. Contract language should specify the original requested date as the baseline, with confirmed-date performance tracked as a separate, secondary figure if the vendor wants credit for meeting revised commitments.
  • Measured how, by whom, over what period? A rolling 30-day or 90-day calculation, drawn from your own receiving records (not the vendor’s self-reported shipping data), stated explicitly in the exhibit.
  • What counts as a miss? Define whether a partial shipment on the correct date counts as on-time for the whole line item or only the units actually delivered — this is a frequent point of dispute if left implicit.

A realistic target range for routine consumables from an established distributor is high (often 95%+), but the number matters far less than the definition behind it — a vague 98% commitment measured against a vendor’s own revised dates is weaker than a precisely defined 92% commitment measured against your PO date.

Order-Accuracy Rate

The percentage of line items received exactly as ordered — correct item, correct quantity, correct lot/expiry within an acceptable window. This should be measured from your own receiving discrepancy log, the same source used for the facility-sourced metrics on an ongoing scorecard, so the SLA commitment and the ongoing measurement use identical data rather than two different counting methods that quietly diverge over time.

Response-Time Commitments for a Service Issue

This is where medical-supply SLAs most often go wrong by importing IT-industry language that doesn’t fit. A generic “4-hour response SLA” borrowed from a software support contract is meaningless without specifying which issue types it covers. A workable structure tiers response commitments by issue severity:

  • Critical/urgent — a stockout risk on a clinically necessary item, a suspected quality or contamination issue, a recall notification. Response commitment measured in hours, sometimes with a separate, faster commitment for an initial acknowledgment versus full resolution.
  • Standard — an invoice discrepancy, a backorder status request, a non-urgent return. Response measured in business days.
  • Administrative — account changes, documentation requests. Longest tier, often not worth a formal SLA commitment at all.

Define “response” as acknowledgment with a named point of contact and next step, not resolution — conflating the two lets a vendor claim compliance by sending a placeholder reply within the window while the actual problem sits unresolved for days. If escalation past the initial contact becomes necessary, that’s a separate, related process — see when to escalate a vendor service failure past the account rep.

Fill Rate and Backorder Handling

Distinct from on-time delivery: this covers what happens when an item can’t ship on the original schedule at all. A useful SLA doesn’t just target a low backorder rate — it specifies what the vendor owes when a backorder does happen: a notification timeline (before or at the original ship date, not discovered by the buyer when the shipment doesn’t arrive), an estimated resupply date, and — for clinically important items — a stated expectation that the vendor identify substitution or emergency-sourcing options rather than leaving the buyer to find them independently.

Remedy Structures: What Happens When a Target Is Missed

The section that gets skipped most often, and the one that determines whether the rest of the exhibit does anything at all. An SLA with performance targets but no consequence for missing them is a statement of intent, not a contract term with teeth. A vendor that consistently misses its own stated target and faces nothing is, in practical terms, operating without an SLA regardless of what the document says.

Service Credits

The most common and most enforceable remedy: a defined percentage credit against the invoice, or a fixed dollar amount, tied to a specific missed threshold over a specific measurement period — for example, a stated credit if on-time delivery falls below the target in a given quarter, scaling with the size of the miss. This needs to be specific enough to calculate without a negotiation each time: which invoices the credit applies against, how it’s calculated, and the deadline for the vendor to apply it.

Corrective Action Plans

For a relationship worth preserving rather than exiting, a remedy tier below termination: a defined trigger (e.g., two consecutive periods below target) that obligates the vendor to produce a written root-cause analysis and corrective plan within a stated number of days, with a follow-up review built into the contract rather than left informal. This is a real remedy when it has a deadline and a required deliverable — a vague obligation to “work together to improve” is not.

Escalating Consequences and Termination Rights

The strongest remedy tier: sustained or repeated SLA failure — defined as a specific pattern (e.g., missing the same metric in three of four consecutive quarters), not a single bad month, which is often normal variance in a small order sample — should trigger an explicit right to terminate for cause, or at minimum a right to exit without the penalties or notice period that would otherwise apply under a standard auto-renewal or wind-down clause. Tying a for-cause exit right to the SLA’s own defined miss-pattern, rather than leaving “cause” undefined, is what keeps this remedy actually usable when it’s needed instead of triggering a separate legal dispute over whether cause exists.

What a Credit Structure Should Avoid

Two common weaknesses worth checking for specifically: a credit capped so low relative to order volume that it’s cheaper for the vendor to simply pay it than fix the underlying problem, and a credit that requires the buyer to proactively claim it (track the miss, calculate the credit, submit a request) rather than one the vendor is obligated to identify and apply automatically. The second is easy to miss during negotiation and expensive to discover later — a credit nobody ever actually collects isn’t functioning as a remedy.

How This Differs From a Vendor Scorecard

It’s worth being precise about the distinction, because the two are often confused: the SLA is the contractual commitment — what the vendor has agreed to be held to, with defined remedies if they miss. The scorecard is the ongoing measurement tool a facility runs to track actual performance against that commitment (and often against other metrics beyond what the SLA covers). A facility can run a scorecard on a vendor with no SLA at all — it just has no contractual remedy attached to what the scorecard shows. Conversely, an SLA with no regular measurement process behind it is a paper commitment nobody is actually checking. The two work together: the SLA defines what “on target” and “off target” mean and what happens in each case; the scorecard is how a facility knows, month to month, which one it’s currently in. See vendor scorecard metrics for the measurement-side framework in full.

Where This Fits in the Broader Contract

An SLA exhibit doesn’t stand alone. It typically attaches to the governing agreement — see MSA vs. individual purchase terms for how that governing document relates to individual orders — and interacts with several other contract elements worth checking for consistency:

  • A warranty or service agreement on equipment covers a different failure mode (a product defect or maintenance need) than a delivery/response SLA on supply orders — don’t assume one substitutes for the other.
  • Vendor onboarding documentation should establish the baseline records (contact points, escalation paths, systems access) an SLA’s response-time commitments depend on being able to actually execute.
  • For single-source or high-dependency vendors, an SLA’s remedy tiers matter more, not less — but they’re not a substitute for a backup-supplier strategy. A credit doesn’t refill a stockout; a qualified second source does.
  • Confirming the vendor carries adequate coverage (see requesting a certificate of insurance) and isn’t subject to exclusion (see debarment and exclusion screening) is a separate but related layer of contract due diligence worth completing alongside SLA negotiation, not instead of it.

Frequently Asked Questions

Does every vendor contract need a formal SLA?

Not every one. A low-volume, low-criticality vendor with occasional orders may not justify the negotiation overhead of a full SLA exhibit — a general service-quality clause in the master agreement may be enough. For high-volume, clinically critical, or single-source vendors, a defined SLA with real remedies is worth the negotiation time; the risk of an undefined “reasonable service” standard is exactly the ambiguity a formal SLA exists to remove.

What’s a realistic on-time delivery target to ask for?

There’s no single defensible industry-wide number, because “on time” is defined differently depending on which date it’s measured against and because acceptable variance differs by product criticality and shipping distance. A more reliable approach than importing a generic benchmark is negotiating the definition first — request-date versus confirmed-date, the measurement window, what counts as a partial miss — then set the numeric target against that specific definition.

Can an SLA be added to an existing vendor contract, or does it require a full renegotiation?

It can often be added as an amendment or exhibit without reopening the entire agreement, particularly at a renewal point or when volume has grown enough to justify formalizing terms that were previously informal. This is a good moment to also review whether the contract’s renewal terms still fit the relationship.

Is a service credit the same as a penalty clause?

Not quite, and the distinction can matter legally in some jurisdictions — a service credit is generally structured as a pre-agreed reduction in the price paid for a service that didn’t fully meet its specification, while a “penalty” (a payment designed purely to punish rather than compensate) can be unenforceable in some contract law systems. Vendors and their counsel will often specifically use “service credit” language for this reason. This is exactly the kind of clause-drafting nuance that benefits from actual legal review of the specific contract language, not general guidance.

This page provides general, informational background on what SLA terms commonly cover in medical-supply vendor contracts. It is not a substitute for review of an actual contract by qualified legal counsel at your institution — remedy structures, enforceability of specific clause language, and jurisdiction-specific contract law considerations should be confirmed with counsel before a contract is signed.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 44,322 indexed passages, and every answer cites the ones it drew on.